Thomas T.

Thomas T. serves as a Board Member at Theolytics and the Principal at Sound Bioventures, where a commitment to advancing science for patients with rare diseases drives the focus. Currently holding roles as Board Observer for multiple companies, including AbolerIS Pharma, Teitur Trophics, Breye Therapeutics ApS, and previously at VarmX and Atox Bio, Thomas has accumulated substantial experience in board governance and leadership in the biotech sector. Academic background includes a D.Phil. in Immunology from the University of Oxford and additional qualifications in Private Equity and Board Leadership.